1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Fluconazole |
| brand | String | Diflucan |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antifungals|Antifungal (triazole)]] • [[:Category:Triazoles|Triazole]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000A42-QINU`"', '"`UNIQ--vote-00000A43-QINU`"', '"`UNIQ--vote-00000A44-QINU`"', '"`UNIQ--vote-00000A45-QINU`"', '"`UNIQ--vote-00000A46-QINU`"' |
| starting_dose | String | Vulvovaginal: 150 mg PO single dose; oropharyngeal: 200 mg PO day 1, then 100 mg daily ×14 days; invasive candidiasis: 800 mg load, then 400 mg PO/IV daily; cryptococcal meningitis: 400-800 mg/d |
| preparations | String | 50, 100, 150, 200 mg tablets; 10, 40 mg/mL oral suspension; 2 mg/mL IV |
| fda_max | String | 800 mg/d (severe invasive disease) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV |
| onset | String | Clinical improvement within 24-72 hours |
| duration | String | 24 hours |
| halflife | String | ~30 hours (long, supports once-daily dosing and substantial drug-interaction window after discontinuation)'"`UNIQ--ref-00000A47-QINU`"' |
| bioavailability | String | >90% (oral; not affected by food or gastric pH — a major practical advantage over itraconazole)'"`UNIQ--ref-00000A48-QINU`"' |
| pregnancy | String | |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
